Tilray Brands, Inc.
TLRY · Medicinal Chemicals and Botanical Products
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Simon Irwin D: Form 4
Insider disclosure · Filed · Report period 26 Aug 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001731348 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- TLRY on Nasdaq
- SEC industry group
- Medicinal Chemicals and Botanical Products (Office of Life Sciences)
- Business address
- 445 Park Avenue, New York, NY, 10022
- Fiscal year end
- 31 May
- Former names on EDGAR
- Tilray, Inc. (to 10 Jan 2022)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields